Show simple item record

dc.contributor.authorGernaat, Sofie A M
dc.contributor.authorBoer, Jolanda M A
dc.contributor.authorvan den Bongard, Desiree H J
dc.contributor.authorMaas, Angela H E M
dc.contributor.authorvan der Pol, Carmen C
dc.contributor.authorBijlsma, Rhodé M
dc.contributor.authorGrobbee, Diederick E
dc.contributor.authorVerkooijen, Helena M
dc.contributor.authorPeeters, Petra H
dc.date.accessioned2018-03-06T08:49:09Z
dc.date.available2018-03-06T08:49:09Z
dc.date.issued2018-02-28
dc.identifier.citationThe risk of cardiovascular disease following breast cancer by Framingham risk score. 2018 Breast Cancer Res. Treat.en
dc.identifier.issn1573-7217
dc.identifier.pmid29492735
dc.identifier.doi10.1007/s10549-018-4723-0
dc.identifier.urihttp://hdl.handle.net/10029/621473
dc.description.abstractThis study evaluates the risk of cardiovascular disease (CVD) following breast cancer, accounting for baseline CVD risk.
dc.language.isoenen
dc.rightsinfo:eu-repo/semantics/closedAccessen
dc.titleThe risk of cardiovascular disease following breast cancer by Framingham risk score.en
dc.typeArticleen
dc.identifier.journalBreast Cancer Res Treat 2018; advance online publication (ahead of print)en
html.description.abstractThis study evaluates the risk of cardiovascular disease (CVD) following breast cancer, accounting for baseline CVD risk.


This item appears in the following Collection(s)

Show simple item record